ChemPartner PharmaTech Co., Ltd. — Investor Relations & Filings
ChemPartner PharmaTech Co., Ltd. is a global research and development organization providing comprehensive drug discovery and development services. Operating as a Contract Research Organization (CRO) and Contract Development and Manufacturing Organization (CDMO), the company supports pharmaceutical and biotechnology clients through an integrated service platform. Core capabilities include medicinal chemistry, biology, pharmacology, drug metabolism and pharmacokinetics (DMPK), and toxicology. The organization also offers specialized expertise in biologics discovery, protein engineering, and antibody development. ChemPartner facilitates the transition from early-stage research to clinical development through its pharmaceutical development and manufacturing capabilities, utilizing advanced technology to accelerate the discovery and production of novel therapeutic agents.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 睿智医药_带与持续经营相关的重大不确定性段落的无保留审计意见报告的专项说明 | 2022-04-29 | Chinese | |
| 独立董事关于第五届董事会第十七次会议相关事项的独立意见 | 2022-04-29 | Chinese | |
| 关于2022年度日常关联交易预计公告 | 2022-04-29 | Chinese | |
| 独立董事2021年度述职报告（汪献忠） | 2022-04-29 | Chinese | |
| 独立董事2021年度述职报告（郭志成） | 2022-04-29 | Chinese | |
| 2022年一季度报告 | 2022-04-29 | Chinese |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2022
15 filings
| |||||
| 36037395 | 睿智医药_带与持续经营相关的重大不确定性段落的无保留审计意见报告的专项说明 | 2022-04-29 | Chinese | ||
| 36037389 | 独立董事关于第五届董事会第十七次会议相关事项的独立意见 | 2022-04-29 | Chinese | ||
| 36037380 | 关于2022年度日常关联交易预计公告 | 2022-04-29 | Chinese | ||
| 36037368 | 独立董事2021年度述职报告（汪献忠） | 2022-04-29 | Chinese | ||
| 36037360 | 独立董事2021年度述职报告（郭志成） | 2022-04-29 | Chinese | ||
| 36037352 | 2022年一季度报告 | 2022-04-29 | Chinese | ||
| 36037344 | 关于召开2021年年度股东大会的通知 | 2022-04-29 | Chinese | ||
| 36037335 | 董事会关于带持续经营重大不确定性段落的无保留意见审计报告涉及事项的专项说明 | 2022-04-29 | Chinese | ||
| 36037328 | 2021年度财务决算报告 | 2022-04-29 | Chinese | ||
| 36037316 | 睿智医药拟进行以财务报告为目的的商誉减值测试所涉及的上海睿智化学研究有限公司含商誉资产组可收回金额项目资产评估报告 | 2022-04-29 | Chinese | ||
| 36037201 | 关于向银行等金融机构申请综合授信额度的公告 | 2022-04-29 | Chinese | ||
| 36037193 | 关于计提商誉减值准备的公告 | 2022-04-29 | Chinese | ||
| 36037187 | 独立董事2021年度述职报告（陈菡） | 2022-04-29 | Chinese | ||
| 36037180 | 关于变更注册地址并修订《公司章程》的公告 | 2022-04-29 | Chinese | ||
| 36037171 | 关于开展商品期货套期保值业务可行性分析报告 | 2022-04-29 | Chinese | ||
Market data
Market data not available
Price history
Peer group · Research and experimental development on natural sciences and engineering
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
1NKEMIA
Biotechnology company providing R&D and services for the li…
|
IKM | ES | Professional, scientific and te… |
|
2cureX AB
Develops an IVD test using 3D tumoroids to predict patient …
|
2CUREX | SE | Professional, scientific and te… |
|
Abattis Bioceuticals Corp.
Life sciences company aggregating and investing in cannabis…
|
ATTBF | CA | Professional, scientific and te… |
|
Abera Bioscience AB
Develops mucosal vaccines using a proprietary Outer Membran…
|
ABERA | SE | Professional, scientific and te… |
|
ABION Inc.
Clinical-stage biopharma developing therapeutics for oncolo…
|
203400 | KR | Professional, scientific and te… |
|
ABL Bio Inc.
Develops bispecific antibody therapeutics for oncology and …
|
298380 | KR | Professional, scientific and te… |
|
Abnova (Taiwan) Corporation
Global leader in high-throughput production of antibodies a…
|
4133 | TW | Professional, scientific and te… |
|
Abpro Holdings, Inc.
Clinical-stage biotech developing antibody therapeutics for…
|
ABP | US | Professional, scientific and te… |
|
Absci Corp
A generative AI drug creation company developing biologic m…
|
ABSI | US | Professional, scientific and te… |
|
Achiko AG
A digital services platform for cross-border business compl…
|
ACHI | CH | Professional, scientific and te… |
ChemPartner PharmaTech Co., Ltd. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/55161/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=55161 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=55161 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=55161 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 55161}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for ChemPartner PharmaTech Co., Ltd. (id: 55161)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.